Noninvasive Colorectal Cancer Screening: Efficacy, Patient Selection, and Impact on Invasive Testing
Since the early 2000s, CRC mortality has significantly decreased, largely due to advancements in screening and the removal of precancerous polyps. However, CRC continues to be the second most common ...
LEIDEN, Netherlands--(BUSINESS WIRE)--Ncardia, a leading human iPSC company, announced today the launch of a new panel of ready-to-use assays designed to streamline the screening and selection of new ...
Noninvasive Colorectal Cancer Screening: Efficacy, Patient Selection, and Impact on Invasive Testing
Patients with an average risk for colorectal cancer (CRC) are candidates for noninvasive tests, such as multitarget stool DNA (mtsDNA), whereas those with a higher risk, including those with a family ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback